SCHEMBL24309802

SCHEMBL24309802

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccccc2F)c1C(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.32
▸ BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309378 0.93 IGF1R (0.30) —
SCHEMBL24309917 0.83 MAPK14 (0.33) MAPK14
SCHEMBL24309882 0.82 MAP4K1 (0.37) BRD4
SCHEMBL24309830 0.81 IGF1R (0.32) MAPK14
SCHEMBL29566707 0.81 HTR1A (0.39) MAPK14BRD4
SCHEMBL24309798 0.81 HTR1A (0.39) MAPK14BRD4
SCHEMBL24309848 0.80 IGF1R (0.32) —
SCHEMBL24310217 0.80 HTR1A (0.31) —
SCHEMBL24309901 0.80 IGF1R (0.33) —
SCHEMBL24310179 0.80 IGF1R (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback